Fitness6 months ago
LILLY’S TIRZEPATIDE REDUCED OBSTRUCTIVE SLEEP APNEA (OSA) SEVERITY, WITH UP TO 51.5% OF PARTICIPANTS MEETING THE CRITERIA FOR DISEASE RESOLUTION
In the primary endpoint, tirzepatide reduced moderate-to-severe OSA severity by up to 62.8% (about 30 fewer events per hour) In a key secondary endpoint from two...
